Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Circular RNAs in diseases, and RNA modifications and cancer.
Precision single-cell profiling of Circulating Tumour Cells: novel markers and data-driven characterization by CTCeek
Druggable Molecular Networks in BRCA1/BRCA2-Mutated Breast Cancer
Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites
Circulating tumor cells share RNA modules with early embryo trophectoderm and with metastatic cancer
From lactation to malignancy: A comparison between healthy and cancerous breast gland at single‐cell resolution reveals new issues for tumorigenesis
Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines
CCR4 <sup>+</sup> CD8 <sup>+</sup> T cells clonally expand to differentiated effectors in murine psoriasis and in human psoriatic arthritis
Circular RNAs Could Encode Unique Proteins and Affect Cancer Pathways
Inverse Impact of Cancer Drugs on Circular and Linear RNAs in Breast Cancer Cell Lines
Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide
Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer
Mitochondria dysfunction in circulating tumor cells
Predictive and Prognostic Value of Non-coding RNA in Breast Cancer
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with “Oncogene-Addicted” Advanced Lung Adenocarcinoma: A Real-World Clinical Study
A KRAS-responsive long non-coding RNA controls microRNA processing
Torque teno mini virus as a cause of childhood acute promyelocytic leukemia lacking PML/RARA fusion
The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2
The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma
Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer
Targeting the Vav1/miR‑29b axis as a potential approach for treating selected molecular subtypes of triple‑negative breast cancer
UC.183, UC.110, and UC.84 Ultra-Conserved RNAs Are Mutually Exclusive with miR-221 and Are Engaged in the Cell Cycle Circuitry in Breast Cancer Cell Lines
Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia
Inhibition of the lncRNA Coded within Transglutaminase 2 Gene Impacts Several Relevant Networks in MCF-7 Breast Cancer Cells
miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis
The network of non-coding RNAs and their molecular targets in breast cancer
Clinical and functional significance of circular RNAs in cytogenetically normal AML
Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset
Expression and functional relevance of long non-coding RNAs in acute myeloid leukemia stem cells
Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia